Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results

BACKGROUND: Sarpogrelate is a selective 5-hydroxytryptamine (5-HT) receptor subtype 2A antagonist which blocks 5-HT induced platelet aggregation and proliferation of vascular smooth muscle cells. We compared the efficacy of sarpogrelate-based dual antiplatelet therapies for the prevention of resteno...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yue-Xin, Wang, Wen-Da, Song, Xiao-Jun, Gu, Yong-Quan, Tian, Hong-Yan, Hu, He-Jie, Zhao, Ji-Chun, Li, Xiao-Qiang, Liu, Chang-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733750/
https://www.ncbi.nlm.nih.gov/pubmed/26063354
http://dx.doi.org/10.4103/0366-6999.158285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733750/
https://www.ncbi.nlm.nih.gov/pubmed/26063354
http://dx.doi.org/10.4103/0366-6999.158285

Ejemplares similares